Non-vascular Stents Market – Global Industry Analysis and Forecast (2022-2029)

Non-vascular Stents Market was valued at US $ 1.64 Bn. in 2021. The global market is expected to grow at a CAGR of 6.4% during the forecast period. The market is expected to reach a value of US $ 2.70 Bn by 2029.
Non-vascular Stents Market Overview:
Non-vascular stents are used to unblock obstructions in non-vascular organs or bodily constructions such as the trachea and bronchi, the oesophagus, the biliary tree, the colon, and the urinary tract. Avascular stent is a petite method that is used to eliminate and preclude heart valve and artery obstructions. It is also engaged to give stenotic or blocked blood arteries internal structural provision.


To know about the Research Methodology:- Request Free Sample Report

It is the procedure of introducing a vascular stent into the body. Polyethene, polypropylene or non-absorbable materials like stainless steel or cobalt-chromium alloys are frequently used in vascular stents. They can range from cylindrical stent-grafts to inflatable metal tangles used during percutaneous vascular interferences to tubular stent grafts for aneurysm management.
Non-vascular Stents Market Dynamics:
Chronic Diseases are becoming more collective which is a major driving factor for the market:

The global occurrence of gastrointestinal disease is on the rise, which is anticipated to fuel the growth of the non-vascular stents market. Every year, over 24,000 Australians are detected with GI cancer, according to the GI Cancer Institute of Australia. In Addition, according to the American Cancer Society, nearly 26,560 which (16,160 in men and 10,400 in women) people in the United States were diagnosed with stomach cancer in 2021. Similarly by 2021, crudely 29,550 new occurrences of stomach cancer will have been identified.

Pulmonic stents are used to open tapering airways and ease the breathing process in conditions like chronic disruptive pulmonary disease, central airway obstruction, and asthma. According to the World Health Organization, more than 3Mn people die each year from chronic obstructive pulmonary disease (COPD), with 90% of these fatality rates befalling in low and middle-income countries like Azerbaijan, Belarus, Botswana, Albania, and Argentina. Kidney disease kills more individuals in the United States each year than prostate or breast cancer.

The high cost of Non-vascular Stents are a major restraining factor for the market:

An increase in the cost of several drugs of stents products and moderate use of dosages is a major factor that is hampering the growth of the market. Furthermore, total costs for those without health insurance range from $11,000 to $41,000 or more, conditional on the type of stent and extent of sojourn in the sanatorium. The National Pharmaceutical Pricing Authority (NPPA) has proclaimed that the expense of a drug-eluting stent would be fixed at $29,600, although the price of bare metal stents will be set at $7,260. In Addition, drug-eluting stents presently cost concerning 40,000 to 1.98 lakh rupees.

Lower Risk of Obstacle and help to avoid epidemic accumulation:

Stenting is a marginally aggressive substitute to coronary artery bypass grafting (CABG) surgery, similar to angioplasty. As a result, the risk of hitches is reduced than with CABG. Patients can commonly leave the hospital the next day, which is a far faster recovery than a CABG operation. Stenting drugs can also help to prevent various diseases such as, relieve chest pain, and promoting good blood flow to the heart, thus these factors give a huge opportunity for the Non-vascular market.

Government regulation and safety concerns among Stents products:

Stringent government rules in some emerging nations such as the United States, Canada and Mexico, as well as safety concerns, are expected to stalemate the development of the Non-Vascular Stents Market.
Non-vascular Stents Market Segment Analysis:
Based on the Product, the market is segmented into Gastrointestinal Stents, Pulmonary Stents, Urological Stents and Others. The Urological Stents segment is expected to hold 35.4% of the overall market share in terms of revenue by 2029. A ureteral stent is also known as a ureteric stent, is a squeaky tube that is positioned into the ureter to avert or treat renal urine flow constraints. The stents utilised in adult patients' assortment in length from 24 to 30 centimetres. Urological Stents are also obtainable in the variability of diameters or devices to accommodate ureters of numerous proportions. A stent is a plastic tube with fleabags in it that is used to lease urine flow from the kidney to the bladder provisionally. They are usually 20-28cm long and have a very gentle smoothness.

However, the Gastrointestinal Stents segment is expected to grow at a CAGR of 2.5% during the forecast period. A gastrointestinal (GI) stent has been formed to discharge obstreperous indications initiated by the variability of syndromes that obstruct the GI tract. Endoscopic stent enclosure has substituted fluoroscopy-guided stent supplement, and self-expanding metal stent (SEMS) has replaced the old type of plastic stent.

Based on Applications, the Non-vascular Stents Market is segmented into Hospitals, Home Care Settings, and Ambulatory Surgical Centers. The Ambulatory Surgical Centers segment is expected to hold 37.5% of the overall market share in terms of revenue by 2029. Ambulatory Surgical Centres (ASC) deliver conveniences in which surgeries do not necessitate hospital admittances. These facilities comprise less traumatic and also deliberated as cost operative for the patients. Biopsies, ACL reconstruction, hernia repair, gastric bypass weight-loss surgery, and cataract surgery are just a few of the procedures that can be accomplished in an ambulatory surgical centre. The most collective ASC is ophthalmology that compacts with eyes.
Non-vascular Stents Market Regional Insights:
The North American region held the largest market share, accounting for 32.78%, in 2021.This is due to the region's admirable healthcare system and the rising occurrence of lung cancer, glaucoma, central airway obstruction, COPD, asthma, and other chronic complaints. Accumulative industrial and material breakthroughs are supporting the expansion of specifically personalized stents for a convention in a variety of suggestions, which is driving the demand for non-vascular stents in a variety of solicitations. The use of stents in pulmonary, gastrointestinal, urological, and biliary censures is rising which is witnessing the growth of the non-vascular market in the U.S and Canada. In the United States, more than 1 Mn intestinal wall hernia conservations are accomplished each year, with inguinal hernia repairs accounting for 780,000 of these illustrations; males account for 92% of all inguinal hernia repairs.

However, the Asia Pacific region is expected to grow at a CAGR of 5.6% during the forecast period. Obligatory healthcare insurance requirements, as well as the increased incidence of gastrointestinal disorders and stomach cancer, are the main factors limiting market expansion in the Asia Pacific. The rising number of inhabitants and increase in apportionment for health care in various countries like India and China is a major reason for driving the growth of the Non-Vascular Stents market in the Asia Pacific region.

The objective of the report is to present a comprehensive analysis of the global market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the market dynamics, structure by analyzing the market segments and projecting the market size. Clear representation of competitive analysis of key players by Technology, price, financial position, product portfolio, growth strategies, and regional presence in the global market makes the report investor's guide.
Non-vascular Stents Market Scope: Inquire before buying



Non-vascular Stents Market


Report Coverage
Details


Base Year:
2021
Forecast Period:
2022-2029


Historical Data:
2017 to 2021
Market Size in 2021:
US $ 1.64 Bn.


Forecast Period 2022 to 2029 CAGR:
6.4%
Market Size in 2029:
US $ 2.70 Bn.


 Segments Covered:
by Application
• Hospitals
• Home Care Settings
• Ambulatory Surgical Centers


by Product
• Gastrointestinal Stents
• Pulmonary Stents
• Urological Stents
• Others



Non-vascular Stents Market, by Region
• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa
Non-vascular Stents Market Key Players
• JINSHAN Science & Technology
• Check-Cap
• Koninklijke Philips N.V.
• ACAMP
• BDD Ltd
• Cerner Corporation.
• FUJIFILM Holdings Corporation
• Given Imaging, Inc.
• Boston Scientific Corporation
• PENTAX Medical
• Medimetrics S.A. de C.V.
• Medisafe
• GE Healthcare
• GENERAL ELECTRIC COMPANY
• Olympus Corporation
Frequently Asked Questions:
1] What segments are covered in the Non-vascular Stents Market report?
Ans. The segments covered in the Non-vascular Stents Market report are based on Product and Application.

2] Which region is expected to held the highest share in the Non-vascular Stents Market?
Ans. The North American region is expected to held the highest share in the Non-vascular Stents Market.

3] What is the market size of the Non-vascular Stents Market by 2029?
Ans. The market size of the Non-vascular Stents Market is expected to be US $ 2.70 Bn by 2029.

4] What is the forecast period for the Non-vascular Stents Market?
Ans. The forecast period for the Non-vascular Stents Market is 2021-2029.

5] What was the market size of the Non-vascular Stents Market in 2021?
Ans. The market size of the Non-vascular Stents Market in 2021 was worth US $ 1.64 Bn.